ZSRM:XETRA:XETRA-BNP Paribas Easy MSCI USA SRI S-Series PAB 5% Capped UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 18.486

Change

-1.13 (-5.76)%

Market Cap

USD 0.07B

Volume

1.03K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.53 (+1.23%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.92 (-1.02%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.44 (+2.00%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.17 (+1.39%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.07 (+1.42%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.19 (+0.87%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.17 (-1.45%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.42 (-0.74%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.08 (-0.82%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.32 (+0.27%)

USD 12.26B

ETFs Containing ZSRM:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -19.77% 18% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.77% 20% F 20% F
Trailing 12 Months  
Capital Gain -10.70% 23% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.70% 25% F 30% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.89% 55% F 56% F
Dividend Return 7.89% 54% F 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.86% 63% D 70% C-
Risk Adjusted Return 79.96% 69% C- 73% C
Market Capitalization 0.07B 31% F 24% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.